2269 trade ideas
Wuxi Biologics (2269): Incredible long-term opportunity! Wuxi Biologics (2269): HKEX:2269
Wuxi Biologics, a Chinese biotech research company listed on the Hong Kong Stock Exchange, presents a complex investment scenario. It's crucial to note we're dealing with the Hong Kong Dollar, not the US dollar. The comprehensive analysis on the weekly chart suggests that since June 2021, the company has been undergoing a correction defense scenario. This downturn has been so pronounced that the stock might need to reach its origin point at 8.56 HKD to complete the correction cycle of Wave 2 through Wave (Y) in blue. This process is expected to involve an initial surge followed by a downturn.
While there's potential for early position building, the decision to do so carries its uncertainties, given regulatory concerns and the stock's unpredictable future. Our strategy is to remain patient, observing how events unfold. Even with a 30% stop-loss threshold, which practically doesn't apply given the upside, we anticipate a minimum 2600% movement for Wave III in red, with the potential to reach an extraordinary 6000% at maximum. Such figures outline the vast upward trajectory expected, not just through Wave 3 but also with an ensuing Wave V.
Therefore, we are comfortable waiting and watching for the right entry point. Even if we decide to enter the market at a later stage, we expect that Wuxi Biologics will still offer significant opportunities.
2269.HK is going to fly ~ (1st target: 77.8, 2nd target: 90.05)2269.HK has experienced a long decline for more than 1 year due to local and oversea government policies, although its P&L has growth a lot. 2269.HK is going to complete a head and shoulder pattern within the last 70 days, and highly likely to fly in the near term. The first target will be 77.8 and second target will be 90.05.
On the other hand, China government is likely to support health and medical industry just to ensure the GDP growth can be met ( 5-6% target this year).
Wuxi Biologics Cayman Inc (2269 - HK) - 5th wave upWuxi Biologics Cayman Inc (2269 - HK) is in 5th wave up of major 5th wave of C wave up in daily time frame. It is now in 5th wave up after sharp 4th wave ended just above wave 1 territory. It also be possible that extension is on the way. But conservatively it is now in 5th wave progress with small invalidation level between. It is also in strong uptrend and out-performing HSI.